Healthcare provider profile · identity verified

Joel A Sagedahl, M.D.

Allopathic & Osteopathic Physicians|Family Medicine · PLYMOUTH, MN · NPI 1235110347

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Joel A Sagedahl, M.D. received $44.12 in general payments during 2025 across 2 reported records.

Medtronic, Inc. accounted for 57.9% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 2 associated products.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$44.12

2 reported records · 2 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Medtronic, Inc.	Medtronic, Inc. exact · evidence 2025-07-22	$25.54	57.9%	1	2025
Eisai Inc.	Unresolved — no canonical attribution shown	$18.58	42.1%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$44.12	2

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
MINIMED 780G Normalized: minimed 780g	Device	Medtronic, Inc.	$25.54	1	2025
Source payment records 2025-03-05 · Medtronic, Inc. · $25.54 · Open Payments source
Leqembi Normalized: leqembi	Drug	Eisai Inc.	$18.58	1	2025
Source payment records 2025-07-15 · Eisai Inc. · $18.58 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	802	231
Metformin Hcl	Metformin Hcl	510	124
Amlodipine Besylate	Amlodipine Besylate	415	119
Losartan Potassium	Losartan Potassium	404	109
Levothyroxine Sodium	Levothyroxine Sodium	399	93
Simvastatin	Simvastatin	330	94
Metoprolol Succinate	Metoprolol Succinate	307	88
Gabapentin	Gabapentin	214	57
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	211	66
Lisinopril	Lisinopril	205	55
Omeprazole	Omeprazole	202	61
Tamsulosin Hcl	Tamsulosin Hcl	167	55
Furosemide	Furosemide	166	43
Hydrochlorothiazide	Hydrochlorothiazide	165	40
Zolpidem Tartrate	Zolpidem Tartrate	158	37
Pregabalin	Pregabalin	154	29
Trazodone Hcl	Trazodone Hcl	137	38
Rosuvastatin Calcium	Rosuvastatin Calcium	128	38
Finasteride	Finasteride	124	40
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	122	36
Warfarin Sodium	Warfarin Sodium	119	24
Allopurinol	Allopurinol	105	33
Atenolol	Atenolol	103	27
Jardiance	Empagliflozin	100	24
Eliquis	Apixaban	94	19
Sertraline Hcl	Sertraline Hcl	91	28
Prednisone	Prednisone	87	45
Glipizide Er	Glipizide	86	27
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	82	suppressed
Ozempic	Semaglutide	80	14
Pantoprazole Sodium	Pantoprazole Sodium	77	27
Bupropion Xl	Bupropion Hcl	76	18
Citalopram Hbr	Citalopram Hydrobromide	76	19
Metoprolol Tartrate	Metoprolol Tartrate	73	21
Donepezil Hcl	Donepezil Hcl	68	16
Duloxetine Hcl	Duloxetine Hcl	67	21
Venlafaxine Hcl Er	Venlafaxine Hcl	67	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	64	18
Alprazolam	Alprazolam	63	19
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	62	suppressed
Oxycodone Hcl	Oxycodone Hcl	61	21
Clopidogrel	Clopidogrel Bisulfate	59	18
Xarelto	Rivaroxaban	57	14
Albuterol Sulfate Hfa	Albuterol Sulfate	52	24
Escitalopram Oxalate	Escitalopram Oxalate	50	suppressed
Alendronate Sodium	Alendronate Sodium	49	16
Meloxicam	Meloxicam	49	suppressed
Potassium Chloride	Potassium Chloride	46	13
Pravastatin Sodium	Pravastatin Sodium	46	12
Clonazepam	Clonazepam	45	suppressed
Fluticasone Propionate	Fluticasone Propionate	44	15
Lovastatin	Lovastatin	43	11
Carvedilol	Carvedilol	42	suppressed
Spironolactone	Spironolactone	42	16
Fluoxetine Hcl	Fluoxetine Hcl	41	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	40	suppressed
Acyclovir	Acyclovir	37	17
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	37	16
Paroxetine Hcl	Paroxetine Hcl	37	14
Tizanidine Hcl	Tizanidine Hcl	37	suppressed
Trulicity	Dulaglutide	37	suppressed
Valacyclovir	Valacyclovir Hcl	37	15
Tramadol Hcl	Tramadol Hcl	36	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	36	suppressed
Famotidine	Famotidine	34	suppressed
Ezetimibe	Ezetimibe	33	11
Metformin Hcl Er	Metformin Hcl	33	11
Montelukast Sodium	Montelukast Sodium	33	11
Mounjaro	Tirzepatide	33	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	32	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	31	11
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	31	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	30	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	30	14
Mirtazapine	Mirtazapine	30	suppressed
Olanzapine	Olanzapine	29	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	29	14
Ondansetron Odt	Ondansetron	28	suppressed
Terbinafine Hcl	Terbinafine Hcl	28	12
Amitriptyline Hcl	Amitriptyline Hcl	27	suppressed
Estradiol	Estradiol	27	suppressed
Glipizide	Glipizide	26	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	26	26
Cephalexin	Cephalexin	25	20
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	25	suppressed
Diazepam	Diazepam	24	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	24	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	24	suppressed
Testosterone Cypionate	Testosterone Cypionate	24	suppressed
Topiramate	Topiramate	23	suppressed
Azithromycin	Azithromycin	22	18
Fludrocortisone Acetate	Fludrocortisone Acetate	22	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Torsemide	Torsemide	22	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	20	12
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	20	13
Januvia	Sitagliptin Phosphate	19	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	19	suppressed
Bupropion Hcl Sr	Bupropion Hcl	18	suppressed
Chlorthalidone	Chlorthalidone	18	suppressed
Klor-Con M20	Potassium Chloride	18	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	18	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	17	15
Digoxin	Digoxin	17	suppressed
Fluocinonide	Fluocinonide	17	suppressed
Gemfibrozil	Gemfibrozil	17	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	17	suppressed
Amoxicillin	Amoxicillin	16	13
Meclizine Hcl	Meclizine Hcl	16	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	16	suppressed
Terazosin Hcl	Terazosin Hcl	16	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	16	suppressed
Baclofen	Baclofen	15	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Fluconazole	Fluconazole	15	suppressed
Humalog Kwikpen U-100	Insulin Lispro	15	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	15	suppressed
Incruse Ellipta	Umeclidinium Bromide	15	suppressed
Ramelteon	Ramelteon	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	14	suppressed
Lorazepam	Lorazepam	13	suppressed
Synthroid	Levothyroxine Sodium	13	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	suppressed
Balsalazide Disodium	Balsalazide Disodium	12	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	12	suppressed
Metronidazole	Metronidazole	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Oxycontin	Oxycodone Hcl	12	suppressed
Rizatriptan	Rizatriptan Benzoate	12	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Butalbital-Aspirin-Caffeine	Butalbital/Aspirin/Caffeine	11	suppressed
Glimepiride	Glimepiride	11	suppressed
Ibuprofen	Ibuprofen	11	suppressed
Memantine Hcl Er	Memantine Hcl	11	suppressed
Naproxen	Naproxen	11	suppressed
Novolog Flexpen	Insulin Aspart	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$44.12 · 2 records	Medtronic, Inc.	Leqembi, MINIMED 780G	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error